Gentex Trims FY21 Revenue Outlook - Quick Facts

While reporting financial results for the second quarter on Friday, automotive products firm Gentex Corp. (GNTX) trimmed its revenue guidance for the full-year 2021 to a range of $1.88 billion to $1.98 billion from the prior outlook range of $1.94 billion to $2.02 billion.

On average, ten analysts polled by Thomson Reuters expect the company to report revenues of $1.99 billion for the year.

The company also projects revenue of $970 million to $1.07 billion in the second half of fiscal 2021.

Looking ahead to fiscal 2022, Gentex said it now expects revenue to be 10 to 15 percent higher than the updated 2021 revenue estimates of $1.88 billion to $1.98 billion, up from the prior estimate for an 8 to 13 percent growth. The Street expects revenues of $2.21 billion for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Huish Outdoors is recalling Oceanic Adult Dry Top Snorkels sold exclusively at Costco citing risk for drowning, U.S. Consumer Product Safety Commission said. The recall involves about 76,000 units of Oceanic Adult Dry Top Snorkels. The recall was initiated after Oceanic received 13 reports of the snorkels leaking. Boeing expects Europe's commercial aviation fleet to need 8,705 new airplanes through 2040 to cater to the growing leisure travel market in the region and fleet replacements with more fuel-efficient models, according to the Boeing's 2021 Commercial Market Outlook (CMO), an annual forecast of long-term demand for commercial airplanes and services. The U.S. Food and Drug Administration authorized marketing of a software developed by Paige.AI, a provider of AI-based digital diagnostics, which could help pathologists to identify prostate cancer. The software, called Paige Prostate, is the first and only artificial intelligence or AI-based pathology product to receive FDA approval for in vitro diagnostic or IVD use in detecting cancer...
Follow RTT